Remuzzi, Andrea
Università degli Studi di Bergamo,
Italy
2025 Rank: 133733
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Biomedical Engineering
Rank in SubField 1: 864 out of 92052 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 133733 | 136379 |
| Total Cites | 772 | 857 |
| H-index | 11 | 11 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 61 | 61 |
| Total Cites to Single+First Authored Papers | 161 | 165 |
| Number of Single+First+Last Authored Papers | 141 | 141 |
| Total Cites to Single+First+Last Authored Papers | 310 | 339 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 664 | 709 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.21 |
| Self-Citation Percentage |
9.92%
|
|
Remuzzi, Andrea
Università degli Studi di Bergamo,
Italy
2024 Rank: 60016
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Biomedical Engineering
Rank in SubField 1: 392 out of 87532 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 60016 | 63798 |
| Total Cites | 839 | 893 |
| H-index | 12 | 12 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 59 | 59 |
| Total Cites to Single+First Authored Papers | 235 | 239 |
| Number of Single+First+Last Authored Papers | 133 | 133 |
| Total Cites to Single+First+Last Authored Papers | 398 | 420 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 746 | 770 |
| Ratio of Total Citations to Distinct Citing Papers | 1.12 | 1.16 |
| Self-Citation Percentage |
6.05%
|
|
Remuzzi, Andrea
Università degli Studi di Bergamo,
Italy
2023 Rank: 72873
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Biomedical Engineering
Rank in SubField 1: 518 out of 82885 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 72873 | 76993 |
| Total Cites | 970 | 1034 |
| H-index | 12 | 13 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 59 | 59 |
| Total Cites to Single+First Authored Papers | 417 | 430 |
| Number of Single+First+Last Authored Papers | 134 | 134 |
| Total Cites to Single+First+Last Authored Papers | 578 | 606 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 873 | 901 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.15 |
| Self-Citation Percentage |
6.19%
|
|
Remuzzi, Andrea
Università degli Studi di Bergamo,
Italy
2022 Rank: 39049
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Biomedical Engineering
Rank in SubField 1: 273 out of 79729 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 39049 | 43944 |
| Total Cites | 1329 | 1367 |
| H-index | 11 | 11 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 59 | 59 |
| Total Cites to Single+First Authored Papers | 761 | 770 |
| Number of Single+First+Last Authored Papers | 132 | 132 |
| Total Cites to Single+First+Last Authored Papers | 930 | 946 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1233 | 1259 |
| Ratio of Total Citations to Distinct Citing Papers | 1.08 | 1.09 |
| Self-Citation Percentage |
2.78%
|
|
Remuzzi, Andrea
Università degli Studi di Bergamo,
Italy
2021 Rank: 28214
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Biomedical Engineering
Rank in SubField 1: 185 out of 76322 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 28214 | 31457 |
| Total Cites | 2236 | 2354 |
| H-index | 16 | 16 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 58 | 58 |
| Total Cites to Single+First Authored Papers | 1402 | 1419 |
| Number of Single+First+Last Authored Papers | 128 | 128 |
| Total Cites to Single+First+Last Authored Papers | 1651 | 1683 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2070 | 2156 |
| Ratio of Total Citations to Distinct Citing Papers | 1.08 | 1.09 |
| Self-Citation Percentage |
5.01%
|
|
Remuzzi, Andrea
Università degli Studi di Bergamo,
Italy
2020 Rank: 144899
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Biomedical Engineering
Rank in SubField 1: 1110 out of 64516 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 144899 | 153008 |
| Total Cites | 625 | 702 |
| H-index | 13 | 13 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 55 | 55 |
| Total Cites to Single+First Authored Papers | 64 | 68 |
| Number of Single+First+Last Authored Papers | 123 | 123 |
| Total Cites to Single+First+Last Authored Papers | 238 | 259 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 517 | 563 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.25 |
| Self-Citation Percentage |
10.97%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.